跳至主要内容
临床试验/JPRN-UMIN000026358
JPRN-UMIN000026358已完成未知

Influence of Lactobacillus salivarius WB21 on small bowel injuries in subjects who take NSAID and PPI; a randomized, double-blind, placebo-controlled trial

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University0 个研究点目标入组 60 人开始时间: 2017年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • Healthy volunteers obtained written informed consent

排除标准

  • 1) Subjects with a history of peptic ulcers
  • 2) Subjects treated continuously with NSAIDs, including aspirin
  • 3) Subjects with a history of aspirin-induced asthma
  • 4) Subjects allergic to sulufonamids
  • 5) Subjects treated with corticosteroid, anti-ulcer drugs (misoprostol, rebamipide, teprenone, etc), or probiotics
  • 6) Subjects with gastrointestinal stenosis or severe adhesion
  • 7) Subjects with malignancy, psychosis, severe hepatic, renal dysfunction, heart disease, or hematologic disease
  • 8) Pregnant and nursing women
  • 9) Subjects with other disorders who are judged inappropriate for the participation of the study

研究者

发起方
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University

相似试验